Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-22-122887)

Filing Details

Accession Number:: 0001104659-22-122887
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-29 16:31:03
Reporting Period:: 2022-11-25

Accepted Time:: 2022-11-29 16:31:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1875558	Nuvectis Pharma Inc.	NVCT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251213	Ron Bentsur	C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024	Chairman & Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-11-25	150	$7.38	3,015,009	No	4	P	Direct
Common Stock	Acquisiton	2022-11-28	150	$7.40	3,015,159	No	4	P	Direct
Common Stock	Acquisiton	2022-11-29	150	$7.45	3,015,309	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 96,759 shares of restricted stock and 120,000 restricted stock units.